Skip to content

Effects of ciprofol on intraoperative hemodynamics in patients undergoing endoscopic thyroidectomy

Effects of ciprofol on intraoperative hemodynamics in patients undergoing endoscopic thyroidectomy: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064543
Enrollment
Unknown
Registered
2022-10-11
Start date
2022-10-11
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid disease

Interventions

Group 1 :Anesthesia was induced and maintained with ciprofol
Group 2:Anesthesia was induced and maintained with propofol

Sponsors

The First Affiliated Hospital of Ji'nan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ASA classification I-II; 2. The age is between 18 and 60 years old; 3. Patients undergoing elective endoscopic thyroidectomy; 4. 18 kg/m2 <= Body Mass Index (BMI) <= 28 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Those who have contraindications to general anesthesia or have a history of anesthesia accidents in the past; 2. Those who are known to be allergic to the active ingredients or auxiliary materials of cyclophosphamide or propofol injection; 3. Complicated with other important organ dysfunction: including severe liver and kidney dysfunction, brain organic diseases or serious cardiopulmonary diseases; 4. Uncontrolled diabetes or hypertension; 5. Patients with a past history of abuse of psychotropic drugs or sedative/narcotic drugs; 6. Nervous system dysfunction, mental illness or cognitive dysfunction; 7. Those who have participated in any drug clinical trials within one month before screening; 8. Pregnant and lactating women; 9. Patients who have taken hormones and non-steroidal anti-inflammatory drugs before operation; 10. Other circumstances in which the researcher judges that the patient is not suitable to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
change of hemodynamic fluctuations;

Secondary

MeasureTime frame
change of BIS value;awakening time;monitor the treatment room stay time after postoperative anesthesia;arterial blood gas;postoperative pain;Postoperative sedative score;Incidence of infusion pain;Incidence of vomiting after surgery;Incidence of hyoxenia;incidence of hypotension;intraoperative vasoactive drug dosage;Incidence of restlessness after surgery;Incidence of intraoperative awareness;

Countries

China

Contacts

Public ContactYalan Li

The First Affiliated Hospital of Jinan University

tyalan@jnu.edu.cn+86 13500013993

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026